







Atlas Genet Cytogenet Oncol Haematol. 2012; 16(8)  518 
INIST-CNRS 
 
OPEN ACCESS JOURNAL 
Atlas of Genetics and Cytogenetics 
in Oncology and Haematology 
BUB1B (budding uninhibited by benzimidazoles 1 
homolog beta (yeast)) 
Sandra Hanks, Katie Snape, Nazneen Rahman 
Institute of Cancer Research, Division of Genetics and Epidemiology, Brookes Lawley Building, 15 
Cotswold Road, Sutton, Surrey SM2 5NG, UK (SH, KS, NR) 
 
Published in Atlas Database: March 2012 
Online updated version : http://AtlasGeneticsOncology.org/Genes/BUB1BID854ch15q15.html 
DOI: 10.4267/2042/47482 
This article is an update of : 
Hanks S, Rahman N. BUB1B (BUB1 budding uninhibited by benzimidazoles 1 homolog beta (yeast)). Atlas Genet Cytogenet Oncol 
Haematol 2005;9(4):285-286. 
 
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France Licence. 
© 2012 Atlas of Genetics and Cytogenetics in Oncology and Haematology 
 
Identity 
Other names: Bub1A, BUBR1, MAD3L, SSK1 




BUB1B spans 60 kb and is composed of 23 exons. 
Protein 
Protein name: BUBR1. 
Description 
1050 amino acids, 120 kDa. 
Expression 
Ubiquituously expressed.  
Preferentially expressed in tissues with a high mitotic 
index. 
Localisation 
Cytoplasmic in interphase cells.  
Bound to BUB3 or CENPE, it can be localised to 
nuclear kinetochores.  
BUBR1 also localises to centrosomes during 
interphase. 
 
Figure 1. Schematic representation of BUB1B demonstrating the relative exon sizes. 
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Figure 2. Schematic representation of BUBR1 demonstrating significant functional or structural domains. 
 
Function 
A central component of the mitotic spindle checkpoint 
that directly inhibits the anaphase-promoting 
complex/cyclosome until sister chromatids are 
correctly attached to the spindle, thus ensuring proper 
chromosome segregation during cell division. Also 
binds the motor protein CENPE, an interaction required 
for regulation of kinetochore-microtubule interactions 
and checkpoint signalling. 
Homology 
BUBR1 is the mammalian homologue of yeast Mad3, a 
significant difference being that BUBR1 possesses a 
kinase domain which is absent in Mad3. 
Mutations 
Note 
Cells from BUB1B mutation-positive cases 
demonstrate an abnormal response to nocodazole-
induced mitotic checkpoint activation. 
Germinal 
Biallelic germline mutations have been found in eight 
MVA pedigrees (figure 3).  
Each family carries one missense mutation and one 
mutation that results in premature protein truncation or 
an absent transcript.  
Monoallelic truncating mutations have also been 
reported in several cases. 
Implicated in 
Mosaic variegated aneuploidy (MVA) 
Note 
MVA is a rare recessive condition characterised by 
mosaic aneuploidies, predominantly trisomies and 
monosomies, involving multiple different 
chromosomes and tissues.  
Affected individuals typically present with severe 
intrauterine growth retardation and microcephaly. Eye 
anomalies, mild dysmorphism, variable developmental 
delay and a broad spectrum of additional congenital 
abnormalities and medical conditions may also occur. 
Prognosis 
There is early mortality in a significant proportion of 
cases due to failure to thrive and/or complications of 
congenital abnormalities, epilepsy, infections or 
malignancy. 
 
Figure 3. Schematic representation of BUB1B demonstrating the relative exon sizes and positions of known mutations. Truncating 
mutations are depicted above the figure, with missense mutations below. Biallelic mutations are represented by coloured lines, with 
mutations in the same individual in matching colours. Monoallelic mutations are represented by black lines and font. 
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Cytogenetics 
The proportion of aneuploid cells varies but is usually 
>10% and is substantially greater than in normal 
individuals. 
Oncogenesis 
The risk of malignancy in MVA is high, with Wilms 
tumour, rhabdomyosarcoma, leukaemia and granulosa 
cell tumour of the ovary reported in several cases. 
Myelodysplastic syndrome has also been observed. 
Three of the eight cases with biallelic BUB1B 
mutations developed a rhabdomyosarcoma and one 
individual developed a granulosa cell tumour of the 
ovary. Wilms tumour and rhabdomyosarcoma have 
been reported in monoallelic BUB1B cases. 
To be noted 
Note 
Biallelic mutations in CEP57 have also been identified 
in individuals with MVA syndrome. 
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